Factors Affecting Therapeutic Effects in 17 Patients with Advanced Hepatocellular Carcinoma Who Were Treated with Sorafenib for More than 12 Months
Conclusion: Achieving favorable therapeutic effects of sorafenib requires strict dose adjustment that allows better control of adverse events and long-term administration of the drug. Furthermore, combining sorafenib with other therapies, a low neutrophil-to-lymphocyte ratio, and a decreased total bilirubin level are useful predictors of favorable effects.Case Rep Oncol 2018;11:711 –720
Source: Case Reports in Oncology - Category: Cancer & Oncology Source Type: research
More News: Bilirubin | Cancer & Oncology | Carcinoma | Hepatocellular Carcinoma | Liver Cancer | Study